Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines

Status:
Active, not recruiting

Trial end date:
2021-11-08

Target enrollment:

Participant gender:

The main objective of this study is to assess safety and tolerability of Intradermal (ID) BOTOX in participants with facial fine lines.

Phase 1

Allergan